Lymphocyte profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: Flow-cytometric characterization and analysis in a two-dimensional correlation biplot

Annals of Hematology

Volumn 76, Issue 6, 1998, Pages 249-256

  Van Den Hove, L E ^a   Meeus, P ^a   Derom, A ^a   Demuynck, H ^a   Verhoef, G E G ^a   Vandenberghe, P ^a   Boogaerts, M A ^a  

^a KU Leuven and University Hospitals Leuven and Leuven Cancer Institute   (Belgium)

Author keywords

Correlation biplot; Flow cytometry; Lymphocyte subsets; Monoclonal gammopathy; Multiple myeloma

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; DEXAMETHASONE; DOXORUBICIN; HLA DR ANTIGEN; MELPHALAN; METHYLPREDNISOLONE; PADGEM PROTEIN; VINCRISTINE;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE SUBPOPULATION; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANALYSIS OF VARIANCE; ANTIGENS, CD; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PARAPROTEINEMIAS;

EID: 0031853281     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050397     Document Type: Article

References (33)

1. Barlogie B, Epstein J, Selvanayagam P, Alexanian R (1989) Plasma cell myeloma - new biological insights and advances in therapy. Blood 73:865-879
2. Boccadoro M, Omedé P, Massaia M, Dianzani U, Pioppo P, Battaglio S, Meregalli M, Pileri A (1988) Human myeloma: several subsets of circulating lymphocytes express plasma cell-associated antigens. Eur J Haematol 40:299-304
3. Carter A, Silvian I, Tatarsky I, Spira G (1986) Impaired immunoglobulin synthesis in multiple myeloma: a B-cell dysfunction. Am J Hematol 22:143-154
4. Commes T, Klein B, Jourdan M, Clofent G, Houssiau F, Grenier J, Bataille R (1989) The defect in peripheral blood B-cell activation in patients with multiple myeloma is not due to a deficiency in the production of B-cell growth and differentiation factors. J Clin Immunol 9:65-73
5. Committee of the Chronic Leukemia-Myeloma Task Forces (1973) Report of the Committee of the Chronic Leukemia-Myeloma Task Force. Cancer Chemother Rep 4:145-158
6. De Rossi G, De Sanctis G, Bottari V, Tribalto M, Lopez M, Petrucci MT, Fontana L (1987) Surface markers and cytotoxic activities of lymphocytes in monoclonal gammopathy of undetermined significance and untreated multiple myeloma. Cancer Immunol Immunother 25:133-136
7. Duperray C, Bataille R, Boiron J-M, Haagen IA, Cantaloube J-F, Zhang X-G, Boucheix C, Klein B (1991) No expansion of the pre-B and B-cell compartments in the bone marrow of patients with multiple myeloma. Cancer Res 51:3224-3228
8. Durie BGM, Salmon SE (1975) A clinical staging system for multiple myeloma. Cancer 36:842-854
9. Greipp PR (1992) Advances in the diagnosis and management of myeloma. Semin Hematol 29 [Suppl 2]: 24-45
10. Hilbert DM, Kopf M, Mock BA, Köhler G, Rudikoff S (1995) Interleukin-6 is essential for in vivo development of B-lineage neoplasms. J Exp Med 182:243-248
11. Hoover RG, Kornbluth J (1992) Immunoregulation of murine and human myeloma. Hematol Oncol Clin North Am 6:407-424
12. Joshua DE (1988) Biology of multiple myeloma - host-tumour interactions and immune regulation of disease activity. Hematol Oncol 6:83-88
13. Kanof ME, James SP (1988) Leu-8 antigen expression is diminished during cell activation but does not correlate with effector function of activated T lymphocytes. J Immunol 140:3701-3706
14. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 323:83-85
15. Kay NE (1995) Circulating blood cells in myeloma. Blood 86:4000 (letter)
16. Kay NE, Oken MM, Kyle R, Van Ness B, Kalish L, Leong T, Greipp P (1995) Sequential phenotyping of myeloma patients on chemotherapy: persistence of activated T-cells and natural killer cells. Leuk Lymphoma 16:351-354
17. +CD28 T cell expansion - anergy or activation? Clin Exp Immunol 104:180-184
18. Kimata H, Sherr EH, Saxon A (1988) Human natural killer (NK) cells produce a late-acting B-cell differentiation activity. J Clin Immunol 8:381-389
19. Ko H-S, Fu SM, Winchester RJ, Yu DTY, Kunkel HG (1979) Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells. J Exp Med 150:246-255
20. Kyle RA (1988) Prognostic factors in multiple myeloma. Hematol Oncol 6:125-130
21. Kyle RA (1992) Diagnostic criteria of multiple myeloma. Hematol Oncol Clin North Am 6:347-358
22. Kyle RA (1993) "Benign" monoclonal gammopathy - after 20 to 35 years of follow-up. Mayo Clin Proc 68:26-36
23. Kyle RA (1994) Monoclonal gammopathy of undetermined significance. Blood Rev 8:135-141
24. Lauria F, Foa R, Cavo M, Gobbi M, Raspadori D, Giubellino MC, Tazzari PL, Tura S (1984) Membrane phenotype and functional behaviour of T lymphocytes in multiple myeloma: correlation with clinical stages of the disease. Clin Exp Immunol 56:653-658
25. Omedé P, Boccadoro M, Gallone G, Frieri R, Battaglio S, Redoglia V, Pileri A (1990) Multiple myeloma: increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor survival. Blood 76:1375-1379
26. Pilarski LM, Jensen GS (1992) Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules. Hematol Oncol Clin North Am 6:297-322
27. Pilarski LM, Mant MJ, Ruether BA (1987) Analysis of immunodeficiency in multiple myeloma: observations and hypothesis. J Clin Lab Anal 1:214-228
28. Pilarski LM, Andrews EJ, Serra HM, Ruether BA, Mant MJ (1989) Comparative analysis of immunodeficiency in patients with monoclonal gammopathy of undetermined significance and patients with untreated multiple myeloma. Scand J Imunol 29:217-228
29. San Miguel JF, González M, Gascon A, Moro MJ, Hernandez JM, Ortega F, Jimenéz R, Guerras L, Romero M, Casanova F, Sanz MA, Sanchez J, Portero JA, Orfao A (1992) Lymphoid subsets and prognostic factors in multiple myeloma. Br J Haematol 80:305-309
30. Spier CM, Grogan TM, Durie BGM, Richter LC, Vela E, Frutiger Y, Rangel CS (1990) T-cell antigen positive multiple myeloma. Mod Pathol 3:302-307
31. Tienhaara A, Pelliniemi T-T (1994) Peripheral blood lymphocyte subsets in multiple myeloma and monoclonal gammopathy of undetermined significance. Clin Lab Haematol 16:213-223
32. Van Camp B, Durie BGM, Spier C, De Waele M, Van Riet I, Vela E, Frutiger Y, Richter L, Grogan TM (1990) Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1 ; Leu-19). Blood 76:377-382
33. Van den Hove LE, Symons F, Vandenberghe P, Verhoef GEG, Demuynck H, Van Gool SW, Ceuppens JL, Boogaerts MA (1997) Multivariate reconstruction of lymphocyte profiles in a two-dimensional graphical model as a tool for the investigation of lymphocyte subset distribution in health and disease. Cytometry 28:220-227